Prospects for Stimulant Maintenance in Vancouver, Canada

References

• Alexander B. K. Peaceful Measures: Canada's Way Out of the War on Drugs. University of Toronto Press, Toronto 1990
   Google Scholar
• Alexander B. K. The globalization of addiction. Addiction Research, (in press)
   Google Scholar
• Archibald C. P., Ofner M., Strathdee S. A., Patrick D. M., Sutherland D., Rekart M. L., Schechter M. T., O'Shaughnessy M. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998; 17: 160–166
   PubMedGoogle Scholar
• Arthritis News Today. Esterene in the treatment of rheumatoid arthritis (editorial) 1980; 2: 5
   Google Scholar
• Avants S. K., Margolin A., De Phillippis D., Kosten T. R. A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine-and opioid-dependent patients. Journal of Substance Abuse Treatment 1998; 15: 261–265
   PubMed Web of Science ®Google Scholar
• Baker R., Anderson J., de Vlaming S., Hickey P., Ross B., Wong C. No further harm - A report of the BCMA's temporary sub-committee on narcotics harm reduction. August 15, 1998, http://www.bcma.org/committees/nofurtherharm.aspReport to the professional advisory committee of the British Columbia Medical Association, 20 pp
   Google Scholar
• Bammer G., Dobler-Mikola A., Fleming P. M., Strang J., Uchtenhagen A. The heroin prescribing debate: Integrating science and politics. Science 1999; 284: 1277–1278
   PubMed Web of Science ®Google Scholar
• Beauchesne L. Une politique publique de réduction des méfaits en matière de drogues: les pièges à éviter. Department of Criminology, Carleton University, Ottawa 2000, Unpublished manuscript
   Google Scholar
• Beebe D. K., Walley E. Smokable amphetamine (“ice”): An old drug in a different form. American Family Physician 1995; 51: 449–453
   PubMed Web of Science ®Google Scholar
• Belding M. A., McLellan A. T., Zaniz D. A., Incmikoski R. Characterizing “nonresponsive” methadone patients. Journal of Substance Abuse Treatment 1998; 15: 485–492
   PubMed Web of Science ®Google Scholar
• Beyerstein B. L., Alexander B. K. Why treat doctors like pushers?. Canadian Medical Association 1985; 132: 337–341
   PubMedGoogle Scholar
• Bourgois P. In search of Horatio Alger: Culture and ideology in the crack economy. Crack in America: Demon Drugs and Social Justice, C. Reinarman, H. G. Levine. University of California Press, Berkeley 1997; 57–76
   Google Scholar
• Boyd S. C. Mothers and Illicit Drugs: Transcending the Myths. University of Toronto Press, Toronto 1999
   Google Scholar
• Brecher E. M. Licit and Illicit Drugs. Little, Brown, Boston 1972
   Google Scholar
• Bruneau J., Lamothe F., Franco E., Lachance N., Desy M., Soto J., Vincelette J. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology 1997; 146: 994–1002
   PubMed Web of Science ®Google Scholar
• Buchanan D. R., Wallack L. This is the Partnership for a Drug-Free America: Any Questions?. Journal of Drug Issues 1998; 28: 329–356
   Web of Science ®Google Scholar
• Budney A. J., Higgins S. T., Bickel W., Kent L. Relationship between intravenous use and achieving initial cocaine abstinence. Drug and Alcohol Dependence 1993; 32: 133–142
   PubMed Web of Science ®Google Scholar
• Catterall W. A., Mackie K. The Pharmacological Basis of Therapeutics, 9th edition, J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, A. G. Gilman. McGraw-Hill, New York 1996; 331–348
   Google Scholar
• Chaisson R. E., Bacchetti P., Osmond M. A., Brodie B., Sande M. A., Moss A. R. Cocaine use and HIV infection in intravenous drug users in San Francisco. Journal of the American Medical Association 1989; 261: 561–565
   PubMed Web of Science ®Google Scholar
• Charnaud B., Griffiths V. Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: A comparison. Drug and Alcohol Dependence 1998; 52: 79–84
   PubMed Web of Science ®Google Scholar
• Chasnoff I., Griffith D., Freier C., Murray J. Cocaine/polydrug use in pregnancy: Two-year follow-up. Pediatrics 1992; 89: 337–339
   PubMedGoogle Scholar
• Cheung Y. W., Erickson P. G. Crack use in Canada: A distant American cousin. Crack in America: Demon Drugs and Social Justice, C. Reinarman, H. G. Levine. University of California Press, Berkeley 1997; 175–193
   Google Scholar
• Chiarello R. J., Cole J. O. The use of psychostimulants in general psychiatry. Archives of General Psychiatry 1987; 44: 286–295
   PubMedGoogle Scholar
• Chiu Y. C., Brecht K., Dasgupta D. S., Mhoon E. Mycardial infarction with topical cocaine anesthesia for nasal surgery. Archives of Otolaryngology - Head and Neck Surgery 1986; 112: 988–990
   PubMedGoogle Scholar
• Cohen P., Sas A. Ten Years of Cocaine: A Follow-up Study of 64 Cocaine Users in Amsterdam. University of Amsterdam, Amsterdam 1993
   Google Scholar
• Cone E. J. Recent discoveries in pharmacokinetics of drugs of abuse. Toxicology Letters 1998; 102–103: 97–101
   PubMed Web of Science ®Google Scholar
• Coppard P. Health board to widen methadone program. October 6, 1996, Vancouver Echo, p. 13
   Google Scholar
• Corty E., Ball J. C. What can we know about addiction from the addicts we treat?. International Journal of the Addictions 1986; 21: 1139–1144
   PubMed Web of Science ®Google Scholar
• Cross-National Collaborative Group. The changing rate of major depression: Cross-national comparisons. Journal of the American Medical Association 1992; 268: 3098–3105
   PubMed Web of Science ®Google Scholar
• Crowly T. J., Brewster J. T. Cocaine legalization: Designing the experiments. Cocaine Abuse: Behavior, Pharmacology, and Clinical Applications, S. T. Higgins, J. L. Katz. Academic Press, San Diego, California 1998; 409–429
   Google Scholar
• DeGrandpre R. J. The impact of socially constructed knowledge on drug policy. Drug Policy and Human Nature: Psychological Perspectives on the Prevention, Management, and Treatment of Illicit Drug Abuse, W. K. Bickel, R. J. De v. Plenum, New York 1996; 251–278
   Google Scholar
• DeGrandpre R. J. Ritalin Nation: Rapid-fire Culture and the Transformation of Human Consciousness. Norton, New York 1999
   Google Scholar
• Drucker E. The failure of prohibition as a drug control strategy: The case of AIDS. Paper presented at the 11th International Conference on Aids, VancouverBritish Columbia, July, 1996, http://www.lindesmith.org/library/grdrucl.htm
   Google Scholar
• Dunn J., Laranjeira R. R. Transitions in the route of cocaine administration - characteristic directions and associated variables. Addiction 1999; 94: 813–824
   PubMed Web of Science ®Google Scholar
• Dupont R. L. Harm reduction and decriminalization in the United States: A personal perspective. Substance Use and Misuse 1996; 31: 1929–1945
   PubMed Web of Science ®Google Scholar
• Erickson P. G., Adlaf E. M., Smart R. G., Murray G. F. The Steel Drug: Cocaine and Crack in Perspective, 2nd edition. Lexington Books, New York 1994
   Google Scholar
• Erickson P. G., Alexander B. K. Cocaine and addictive liability. Social Pharmacology 1989; 3: 249–270
   Google Scholar
• Harm Reduction: A New Direction for Drug Policies and Programs, P. G. Erickson, D. M. Riley, Y. W. Cheung, P. A. O'Hare. University of Toronto Press, Toronto 1997
   Google Scholar
• Feehan H. F., Mancusi-Ungaro A. The use of cocaine as a topical anesthetic in nasal surgery: A survey report. Plastic and Reconstructive Surgery 1976; 57: 62–65
   PubMed Web of Science ®Google Scholar
• Fernandez F., Maldonado J., Ruiz P. Neuropsychiatric complications. Substance Abuse: A Comprehensive Textbook, 3rd edition, J. H. Lowinson, P. R. Ruiz, B. Millman, J. G. Langrod. Williams and Wilkins, Baltimore 1997; 207–223
   Google Scholar
• Findling R. L. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: A case series. Journal of Child and Adolescent Psychopharmacology 1996; 6: 165–175
   PubMed Web of Science ®Google Scholar
• Finkle B. S., McClosky K. L. The forensic toxicology of cocaine (1971–1976). Journal of Forensic Sciences 1978; 23: 173–189
   PubMed Web of Science ®Google Scholar
• Fischer B. Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada. Journal of Public Health Policy 2000; 21: 187–210
   PubMed Web of Science ®Google Scholar
• Fischman M. W., Schuster C. R., Resnekov L., Shick J. F. E., Krasnegor N. A., Fennell W., Freedman D. X. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Archives of General Psychiatry 1976; 33: 983–989
   PubMed Web of Science ®Google Scholar
• Fisher D. G., Fenaughty A. M., Trubatch B. Seroconversion issues among out-of-treatment injection drug users. Journal of Psychoactive Drugs 1998; 30: 299–305
   PubMed Web of Science ®Google Scholar
• Fleming P. M. Prescribing amphetamine to amphetamine users as a harm reduction measure. 1998; 17, Unpublished manuscript
   Google Scholar
• Fleming P. M., Roberts D. Is the prescription of amphetamine justified as a harm reduction measure?. Journal of the Royal Society of Health 1994; 114: 127–131
   PubMedGoogle Scholar
• Foss K. New medical study questions benefit of choosing Prozac: Side effects of several leading antidepressants found to be similar to older, cheaper drugs. The Globe and Mail November 17, 1998; A10
   Google Scholar
• Freedman D. Experts push legalization of cocaine gum to wean addicts, http://www.druglibrary.org/schaffer/cocaine/cocagum.htmReport distributed by the Hearst News Service: 2 pp, (undated)
   Google Scholar
• Frierson R. L., Wey J. J., Tabler J. B. Psychostimulants for depression in the medically ill. American Family Physician 1991; 43: 163–170
   PubMed Web of Science ®Google Scholar
• Frye C. B. Methylphenidate for depression in the elderly, medically ill patient. American Journal of Health-System Pharmacy 1997; 54: 2510–2511
   PubMedGoogle Scholar
• Gawin F., Riordan C., Kleber H. Methylphenidate treatment of cocaine abusers without attention deficit disorder: A negative report. American Journal of Drug and Alcohol Abuse 1985; 11: 193–197
   PubMed Web of Science ®Google Scholar
• Goldberg L. Drug abuse in Sweden. United Nations Bulletin on Narcotics 1968; 2: 9–36
   Google Scholar
• Goldstein P. J., Brownstein H. H., Ryan P. J., Bellucci P. A. Crack and homicide in New York City: A case study in the epidemiology of violence. Crack in America: Demon Drugs and Social Justice, C. Reinarman, H. G. Levine. University of California Press, Berkeley 1997; 113–130
   Google Scholar
• Gordon B. R. Topical cocaine in nasal anesthesia. Archives of Otolaryngology -Head and Neck Surgery 1987; 113: 211
   PubMedGoogle Scholar
• Gorelick D. A. Pathophysiologic effects of cocaine in humans: Review of scientific issues. Journal of Addictive Diseases 1992; 11: 97–110
   PubMedGoogle Scholar
• Gorelick D. A. The rate hypothesis and agonist substitution approaches to cocaine abuse treatment. Advances in Pharmacology 1998; 42: 995–997
   PubMedGoogle Scholar
• Grabowski J., Roache J. D., Schmitz J. M., Rhoades H., Creson D., Korszun A. Replacement medication for cocaine dependence: Methylphenidate. Journal of Clinical Psychopharmacology 1997; 17: 485–488
   PubMed Web of Science ®Google Scholar
• Grant S. A. D., Hoffman R. S. Use of tetracaine, epinephrine, and cocaine as a topical anesthetic in the emergency department. Annals of Emergency Medicine 1992; 21: 987–997
   PubMedGoogle Scholar
• Greenhill L. L., Osman B. B. Ritalin: Theory and Practice, 2nd edition. Mary Ann Liebert, Larchmont, New York 2000
   Google Scholar
• Grinspoon L., Grinspoon J. B. Cocaine: A Drug and its Social Evolution. Basic Books, New York 1976
   Google Scholar
• Grinspoon L., Bakalar J. B. Coca and cocaine as medicines: An historical review. Journal of Ethnopharmacology 1981; 3: 149–159
   PubMed Web of Science ®Google Scholar
• Grinspoon L., Hedblom P. The Speed Culture: Amphetamine Use and Abuse in America. Harvard University Press, Cambridge, MA 1975
   Google Scholar
• Hall S. M., Clark H. W., Lea Sees K. Drug abuse, drug treatment, and public policy. Drug Policy and Human Nature: Psychological Perspectives on the Prevention, Management, and Treatment of Illicit Drug Abuse, W. K. Bickel, R. J. De Grandpre. Plenum, New York 1996; 77–98
   Google Scholar
• Hando J., Topp L., Hall W. Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug and Alcohol Dependence 1997; 46: 105–113
   PubMed Web of Science ®Google Scholar
• Huber A., Ling W., Shoptaw S., Gulati V., Brethen P., Rawson R. Integrating treatments for methamphetamine abuse: A psychosocial perspective. Journal of Addictive Diseases 1997; 16: 41–50
   PubMed Web of Science ®Google Scholar
• Hurtado Gumucio J. Cocaine, the Legend: About Coca and Cocaine. Accion Andina, Bolivia 1995
   Google Scholar
• Jaffe S. F. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry 1991; 30: 773–775
   PubMed Web of Science ®Google Scholar
• Johns M. E., Henderson R. L. Cocaine use by the otolaryngologist: A survey. Transactions of the American Academy of Ophthalmology and Otolaryn-gology: Section on Ophthalmology 1977; 84: 969–973
   Google Scholar
• Khantzian E. J. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. American Journal of Psychiatry 1983; 140: 784–785
   PubMed Web of Science ®Google Scholar
• Khantzian E. J. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence. American Journal of Psychiatry 1985; 142: 1259–1264
   PubMed Web of Science ®Google Scholar
• Khantzian E. J., Gawin F., Kleber H. D., Riordan C. E. Methylphenidate (Ritalin) treatment of cocaine dependence - a preliminary report. Journal of Substance Abuse Treatment 1984; 1: 107–112
   PubMedGoogle Scholar
• King G. R., Ellinwood E. H. Amphetamines and other stimulants. Substance Abuse: A Comprehensive Textbook, 2nd edition, J. H. Lowinson, P. Ruiz, R. B. Millman, J. G. Langrod. Williams and Wilkens, Baltimore 1992; 247–270
   Google Scholar
• King G. R., Ellinwood E. H. Amphetamines and other stimulants. Substance Abuse: A Compreehensive Textbook, 3rd edition, J. H. Lowinson, P. Ruiz, R. B. Millman, J. G. Langrod. Williams and Wilkens, Baltimore 1997; 207–223
   Google Scholar
• Kollins S. H., Rush C. R., Pazzaglia P. J., Ali J. A. Comparison of acute behavioral effects of sustained-release and immediate release methylphenidate. Experimental and Clinical Psychopharmacology 1998; 6: 367–374
   PubMed Web of Science ®Google Scholar
• Krai A. H., Bluthenthal R. N., Booth R. E., Watters J. K. HIV seropre-valence among street-recruited injection drug and crack cocaine users in 16 US municipalities. American Journal of Public Health 1998; 88: 108–113
   PubMedGoogle Scholar
• Ledain G. Final Report of the Commission of Inquiry into the Non-medical Use of Drugs. Information Canada, Ottawa 1973
   Google Scholar
• Levin F. R., Evans S. M., Kleber H. D. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence 1998a; 52: 15–25
   PubMed Web of Science ®Google Scholar
• Levin F. R., Evans S. M., McDowell D. M., Kleber H. D. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: A pilot study. Journal of Clinical Psychiatry 1998b; 59: 300–305
   PubMed Web of Science ®Google Scholar
• Levin F. R., Evans S. M., Kleber H. D. Practical guidelines for the treatment of substance abusers with adult attention-deficit disorder. Psychiatric Services 1999; 50: 1001–1003
   PubMed Web of Science ®Google Scholar
• Levin F. R., Kleber H. D. Attention-deficit hyperactivity disorder and substance abuse: Relationships and implications for treatment. Harvard Review of Psychiatry 1995; 2: 246–258
   PubMed Web of Science ®Google Scholar
• Lindesmith, Center. Heroin Maintenance Treatment: Research Summary. The Lindesmith Center, New York 1998
   Google Scholar
• Lintzeris N., Holgate F., Dunlop A. Addressing dependent amphetamine use: A place for prescription. Drug and Alcohol Review 1996; 15: 189–195
   PubMed Web of Science ®Google Scholar
• Little K. Y. d-Amphetamine versus methylphenidate effects in depressed patients. Journal of Clinical Psychiatry 1993; 54: 349–355
   PubMedGoogle Scholar
• Llosa T. R. Coca: Uses and Abuses. DESA, Lima 1991, COCADI
   Google Scholar
• Llosa T. R. The standard low dose of oral cocaine used for treatment of cocaine dependence. Substance Abuse 1994; 15: 215–220
   Google Scholar
• Llosa T. R. “Cocalization”: The standard low dose of oral cocaine used for treatment of cocaine dependence. Journal of Chemical Addiction 1995; 6: 1–16
   Google Scholar
• Maier H. W. Cocaine Addiction, O. J. Kalant. Alcoholism and Drug Addiction Research Foundation, Toronto 1926/1987
   Google Scholar
• Maté G. Scattered Minds: A New Look at the Origins and Healing of Attention Deficit Disorder. Knopf Canada, Toronto 1999
   Google Scholar
• Matthews L. C. B., Dawes G. A., Nadeau B. G., Wong L. S., Alexander B. K. The British Columbia Key Informant Study. 1994, Report to the World Health Organization, Geneva, Switzerland, 52 pp
   Google Scholar
• Mattick R. P., Darke S. Drug replacement treatments: Is amphetamine substitution a horse of a different colour?. Drug and Alcohol Review 1995; 14: 389–394
   PubMed Web of Science ®Google Scholar
• McBride A. J., Sullivan G., Blewett A. E., Morgan S. Amphetamine prescribing as a harm reduction measure: A preliminary study. Addiction Research 1997; 5: 95–112
   Web of Science ®Google Scholar
• Meier B. Suits charge conspiracy by maker and doctors' group to expand Ritalin use. October 25, 2000, http://www.nytimes.com/2000/09/14/science/14RITA.htmlThe New York Times on the web
   Google Scholar
• Merill J. Evaluation of prescribing dexamphetamine in the treatment of amphetamine dependence. 1998; 10, Unpublished manuscript
   Google Scholar
• Meyers M. G., Rohsenhow D. J., Monte P. M., Dey A. Patterns of cocaine use among individuals in substance abuse treatment. American Journal of Drug and Alcohol Abuse 1995; 21: 223–231
   PubMedGoogle Scholar
• Morales E. Cocaine: White Gold Rush in Peru. University of Arizona Press, Tucson 1989
   Google Scholar
• Morgan J. P., Zimmer L. The social pharmacology of smokable cocaine: Not all it's cracked up to be. Crack in America: Demon Drugs and Social Justice, C. Reinarman, H. G. Levine. University of California Press, Berkeley 1997a; 131–170
   Google Scholar
• Morgan J. P., Zimmer L. Animal self-administration of cocaine: Misinterpretation, misrepresentation, and invalid extrapolation to humans. Harm Reduction: A New Direction for Drug Policies and Programs, P. G. Erickson, D. M. Riley, Y. W. Cheung, P. A. O'Hare. University of Toronto Press, Toronto 1997b, (1997)
   Google Scholar
• Mortimer W. G. History of Coca: “The Devine Plant” of the Incas. Fitz High Ludlow Memorial Library, San Francisco 1901/1974
   Google Scholar
• Mugford S. K., Cohen P. J. Drug use, social relations and commodity consumption: A study of cocaine users in Sydney, Canberra and Melbourne. 1989, Report to the Research into Drug Abuse Advisory Committee, NCADA
   Google Scholar
• Nadelmann E. A. March, 1996, http://www.ihra.org.uk/paris/proceedings/nadelmann.htmOn harm reduction. Paper presented at the 8th International Conerence on the Reduction of Drug Related Harm, Paris, France.
   Google Scholar
• Nadelmann E. A. Drug prohibition in the US: Costs and consequences. Crack in America: Demon Drugs and Social Justice, C. Reinarman, H. G. Levine. University of California Press, Berkeley 1997; 288–316
   Google Scholar
• National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. Journal of the American Medical Association 1998; 280: 1936–1943
   PubMed Web of Science ®Google Scholar
• O'Brien C. P. Drug addiction and drug abuse. The Pharmacological Basis of Therapeutics, 9th edition, J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, A. G. Gilman. McGraw-Hill, New York 1996; 557–577
   Google Scholar
• Paly D., Jatlow P., Van Dyke C., Cabieses F., Byck R. Plasma levels of cocaine in native Peruvian coca chewers. Cocaine 1980, F. R. Jeri. Pacific Press, Lima, Peru 1980
   Google Scholar
• Parran T. V., Jasinski D. R. Intravenous methylphenidate abuse: Prototype for prescription drug abuse. Archives of Internal Medicine 1991; 151: 781–783
   PubMed Web of Science ®Google Scholar
• Pates R. Speed on prescription. Druglink 1994; 16–17, May/June
   Google Scholar
• Peele S. Assumptions about drugs and the marketing of drug policies. Drug Policy and Human Nature: Psychological Perspectives on the Prevention, Management, and Treatment of Illicit Drug Abuse, W. K. Bickel, R. J. De Grandpre. Plenum, New York 1996; 199–218
   Google Scholar
• Peele S., De Grandpre R. J. Cocaine and the concept of addiction: Environmental factors in drug compulsions. Addiction Research 1998; 6: 235–263
   Google Scholar
• Perrine D. M. The Chemistry of Mind-Altering Drugs. American Chemical Society, Washington, D.C. 1996
   Google Scholar
• Plume D. The self-medication hypothesis: ADHD and chronic cocaine abuse. 1995; 19, http://www.druglibrary.org/schaffer/cocaine/addhyp.htmUnpublished literature review
   Google Scholar
• Post R. M., Kotin J., Goodwin F. K. The effects of cocaine on depressed patients. American Journal of Psychiatry 1974; 131: 511–517
   PubMed Web of Science ®Google Scholar
• Poulin C., Fralick P., Whynot E. M., el-Guebaly N., Kennedy D., Bernstein J., Boivin D., Rinehart J. The epidemiology of cocaine and opiate abuse in urban Canada. Canadian Journal of Public Health 1998; 89: 234–238
   PubMedGoogle Scholar
• Rees A. April 3, 1998, Ritalin use in Canada jumps 547%. The Vancouver Province, p. A17
   Google Scholar
• Reichman O. S., Otto R. A. The effect of intranasal cocaine on the urine drug screen for benzoylecgonine. Otolaryngology: Head and Neck Surgery 1992; 106: 223–225
   PubMedGoogle Scholar
• Crack in America: Demon Drugs and Social Justice, C. Reinarman, H. G. Levine. University of California Press, Berkeley 1997
   Google Scholar
• Reinarman C., Waldorf D., Murphy S. B., Levine H. G. The contingent call of the pipe: Bingeing and addiction among heavy cocaine smokers. Crack in America: Demon Drugs and Social Justice, C. Reinarman, H. G. Levine. University of California Press, Berkeley 1997; 77–97
   Google Scholar
• Riordan H. J., Flashman L. A., Saykin A. J., Frutiger S. A., Carroll K. E., Huey L. Neuropsychological correlates of methylphenidate treatment in adult ADHD with and without depression. Archives of Clinical Neuropsychology 1999; 14: 217–233
   PubMed Web of Science ®Google Scholar
• Rosenbaum M., Washburn A., Knight K., Kelley M., Irwin J. Treatment as harm reduction, defunding as harm maximization: The case of methadone maintenance. Journal of Psychoactive Drugs 1996; 28: 241–249
   PubMed Web of Science ®Google Scholar
• Safer D. J., Zito J. M. Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of attention deficit hyperactivity disorder. Ritalin: Theory and Practice, 2nd edition, L. L. Greenhill, B. B. Osman. Mary Ann Liebert, Larchmont, New York 2000; 7–26
   Google Scholar
• Sannerud C., Feussner G. Is Ritalin an abused drug? Does it meet the criteria of a Schedule II substance?. Ritalin: Theory and practice, 2nd edition, L. L. Greenhill, B. B. Osman. Mary Ann Liebert, Larchmont, New York 2000; 27–42
   Google Scholar
• Schenck N. L. Local anesthesia in otolaryngology: A re-evaluation. Annals of Otology, Rhinology and Laryngology 1975; 84: 65–72
   PubMedGoogle Scholar
• Sherman J. Dexamphetamine for “speed” addiction. The Medical Journal of Australia 1990; 153: 306
   PubMed Web of Science ®Google Scholar
• Shoenbaum E. E., Hartel D., Selwyn P. A., Klein R. S., Davenny K., Rogers M., Feiner C., Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine 1989; 321: 874–879
   PubMedGoogle Scholar
• Siegel R. K. Intoxication: Life in Pursuit of Artificial Paradise. Dutton, New York 1989
   Google Scholar
• Siegel R. K., Elsohly M. A., Plowman T., Rury P. M., Jones R. T. Cocaine in herbal tea. Journal of the American Medical Association 1986; 255: 40
   Google Scholar
• Springer E. Effective AIDS prevention with active drug users: The harm reduction model. Journal of Chemical Dependency Treatment 1991; 4: 141–157
   Google Scholar
• Strang J., Sheridan J. Prescribing amphetamines to drug misusers: Data from the 1995 national survey of community pharmacies in England and Wales. Addiction 1997; 92: 833–838
   PubMedGoogle Scholar
• Strathdee S. A., Patrick D. M., Archibald C. P., Ofner M., Cornelisse P. G. A., Rekart M., Schechter M. T., O'Shaugnessy M. V. Social determinants predict needle-sharing behavior among injection drug users in Vancouver, Canada. Addiction 1997a; 92: 1339–1347
   PubMed Web of Science ®Google Scholar
• Strathdee S. A., Patrick D. M., Currie S. L., Cornelisse P. G. A., Rekart M. L., Montaner J. S. G., Schechter M. T., O'Shaughnessy M. V. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS 1997b; 11: F59–65
   PubMed Web of Science ®Google Scholar
• Szasz T. The fatal temptation: Drug prohibition and the fear of autonomy. Daedalus 1992; 121: 161–164
   Google Scholar
• Thase M. E., Rush A. J. Treatment-resistant depression. Psychopharmacology: Fourth Generation of Progress, F. E. Bloom, D. J. Kupfer. Raven Press, New York 1995; 1081–1097
   Google Scholar
• Trebach A. The Heroin Solution. Yale University Press, New Haven 1982
   Google Scholar
• Trebach A. The Great Drug War: And Radical Proposals that Could Make America Safe Again. Macmillan, New York 1987
   Google Scholar
• Tsou J. Y. Attitudes towards harm reduction among injection drug users in a Vancouver shelter. August, 2000, Report to the Portland Hotel Society, Vancouver, British Columbia, 32 pp
   Google Scholar
• Van Dyke C., Barash P. G., Jatlow P., Byck R. Cocaine plasma concentrations after intranasal application in man. Science 1976; 191: 859–861
   PubMed Web of Science ®Google Scholar
• Volkow N. D., Ding Y. S., Fowler J. S., Wang G. J., Logan J., Gatley J. S., Dewey S., Ashby C., Liebermann J., Hitzemann R., Wolf A. P. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Archives of General Psychiatry 1995; 52: 456–463
   PubMed Web of Science ®Google Scholar
• Washton A. M., Tatarsky A. Adverse effects of cocaine abuse. NIDA Research Monograph 1984; 49: 247–254
   PubMedGoogle Scholar
• WHO/UNICRI. Cocaine Project. World Health Organization, Geneva 1995, (Available from the World Health Organization)
   Google Scholar
• Wong L. S., Alexander B. K. Cocaine-related deaths: Media coverage in the War on Drugs. Journal of Drug Issues 1991; 21: 105–119
   Google Scholar